SCHEMBL6270768

SCHEMBL6270768

CCCCOc1c(O)c2cccc(OCCO)c2oc1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 7/20 0.47
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ADORA3 P0DMS8 3/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PLA2G1B P04054 1/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
CYP2A6 P11509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6270575 0.96 CNR2 (0.43) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6276043 0.95 CNR2 (0.43) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6276238 0.95 CNR2 (0.43) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6277139 0.95 CNR2 (0.43) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6275622 0.95 CNR2 (0.43) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6276187 0.95 CNR2 (0.47) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6273106 0.94 CNR2 (0.46) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6275949 0.94 CYP2A6 (0.43) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6270731 0.91 CNR2 (0.43) CNR2KDM4EALDH1A1LMNAMAPT
SCHEMBL6276200 0.91 CNR2 (0.43) CNR2KDM4EALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 EP disclosed
CN-1473565-A Benzopyrany/derivatives and antiallergic agent ���ձ���ī��ѧ��ʽ���� 2004-02-11 CN disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 CNR2 249/4885KDM4E 965/4885ALDH1A1 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.